A new diagnostic algorithm for an early diagnosis of patients with fragile X syndrome
1United States Food and Drug Administration (USFDA), 10903 New Hampshire Avenue, Building 22, Room 4191 Silver Spring, MD 20993, USA.
Neurology India
|November 15, 2016
Abstract
No abstract available in PubMed .
More Related Videos
11:10Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
2.7K
10:59Generation and Characterization of Human Induced Pluripotent Stem Cell-derived Astrocytes Lacking Fragile X Messenger Ribonucleoprotein
Published on: June 6, 2025
1.2K
